Friday, February 24, 2006
GTC Biotherapeutics have applied to the European Medicines Agency (EMEA) to license Atryn, a recombinant form of human antithrombin, extracted from the milk of genetically modified goats. As reported by the BBC, granting of the licence would mean that Atryn will be the world's first medicine to be produced from a genetically modified animal. In Wisconsin, Pharming is working on a herd of transgenic cows that express human lactoferrin in their milk, for which they have just filed a GRAS (Generally Recognized As Safe) notification with the US FDA. In the Netherlands, the same company is milking rabbits for recombinant human C1 inhibitor, for treatment of hereditary angiodema.
"milking a rabbit"